Studies have shown that G protein signaling 16 (RGS16) can act as a tumor suppressor by inhibiting the growth of PI3K dependent breast epithelial cells (82), while inhibiting PI3K/AKT downregulates REST expression and induces NE markers in LNCaP, PC3 and LNCaP95 cells (83). This evidence concerns the gene RGS16 and neoplasm.